Anti-ZMYND8 Rabbit Polyclonal Antibody

Algentbio Antibody
Algentbio Antibody

Anti-ZMYND8 Rabbit Polyclonal Antibody

Rabbit IgG Polyclonal for ZMYND8 detection, Test with WB in Human, Mouse, Rat

Reactivity
  • Human
  • Mouse
  • Rat
Application
  • WB
Host
  • Rabbit
Catalog Number
    ABXB07157
$340.00

Shipping To:
United States

Product Information

Downloads & Supports

Target
    ZMYND8
Host
  • Rabbit
Storage
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Clonality
  • Polyclonal
Clone Number
    -
Isotype
    IgG
Reactivity
  • Human
  • Mouse
  • Rat
Application
  • WB
Application Details
    WB: 1/500-1/1000
Immunogen
    Synthetic peptide corresponding to Human Rack7.
Molecular Weight
    Calculated MW: 132kDa
Formulation
    1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.
Form
    Liquid
Gene ID
    23613
Uniprot ID
    Q9ULU4
Background
    Zinc finger MYND domain-containing protein 8 (ZMYND8), also referred to as receptor for activated C-kinase 7 (Rack7) and protein kinase C-binding protein 1 (PRKCBP1), is a DNA damage response protein and a transcriptional regulator that is a close homolog of ZMYND11 (BS69). ZMYND8 binds to H3K36me2 and H4K16ac, two histone marks associated with active transcription. This protein is targeted to sites of DNA damage within actively transcribed genes, and recruits the H3K4me3-specific histone demethylase KDM5A/JARID1A and nucleosome remodeling and histone deacetylation (NuRD) complex. Together, these protein complexes mediate transcriptional repression and allow for subsequent double-strand break repair via homologous recombination. ZMYND8 contains a bromodomain and a PWWP domain near its N-terminus, and a MYND domain towards the C-terminus, the latter of which mediates interaction with the NuRD complex. ZMYND8 also functions to recruit the H3K4me3-specific histone demethylase KDM5C/JARID1C to enhancer and super-enhancer regions, and functions as a negative regulator of gene expression. ZMYND8 and JARID1C are both putative tumor suppressor proteins, and knockdown of either of these proteins leads to derepression of S100 oncogenes. ZMYND8 expression is altered in breast and cervical cancer, and has been found to be translocated with RELA in at least one patient with acute erythroid leukemia. Knock-down of ZMYND8 expression in breast cancer cell lines increases anchorage-independent cell growth, cell migration and invasion, and tumor growth in mouse xenograft models.
Research Area
    -
Synonyms
    Protein kinase C-binding protein 1; Cutaneous T-cell lymphoma-associated antigen se14-3; CTCL-associated antigen se14-3; Rack7; Zinc finger MYND domain-containing protein 8; ZMYND8; KIAA1125; PRKCBP1; RACK7
MSDSProtocolsRequest COAAlgent Product GuaranteeNeed support?

Product Image